Author:
Ralph Angelique F,Ager Brittany,Bell Melanie L,Collins Ian M,Andrews Lesley,Tucker Kathy,O’Reilly Nicole,Phillips Kelly-Anne,Butow Phyllis
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg Å, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003, 72(5):1117-1130. doi:10.1086/375033
2. Australian Institute of Health and Welfare: Breast cancer in Australia: an overview, 2009 (Cancer series no. 50. Cat. no. CAN 46. Cancer series no. 50. Cat. no. CAN 46. AIHW, Canberra; 2009.
3. Black WC, Nease RF, Tosteson ANA: Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 1995, 87(10):720-731. doi:10.1093/jnci/87.10.720
4. Bober SL, Hoke LA, Duda RB, Regan MM, Tung NM: Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors. J Clin Oncol 2004, 22(24):4951-4957. doi:10.1200/jco.2004.05.192
5. Collins IM, Milne RL, Weideman P, McLachlan SA, Friedlander ML, Hopper JL, Phillips KA, kConFab Investigators: Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers. (kConFab). Med J Aust 2013, 199: 680-683. 10.5694/mja13.10848
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献